copyright: johnhoulihan.com

World-class facilities, including the newly-opened Wolfson Laboratories

copyright: johnhoulihan.com

Integrating the study of basic and clinical immunology, microbiology and parasitology

copyright: johnhoulihan.com

Developing a greater understanding of processes underlying infection and disease development

copyright: johnhoulihan.com
copyright: johnhoulihan.com

Innovation through forging stronger links between biology and medicine

copyright: johnhoulihan.com

Cutting-edge research into preventions and cures for chronic infectious diseases

copyright: johnhoulihan.com

International impact on fighting neglected tropical diseases

Welcome

The Centre for Immunology and Infection (CII) is a joint research centre created by the Hull York Medical School and the Department of Biology at the University of York.

Research within CII ranges from fundamental studies on the pathogenesis of infectious and non-infectious disease through to first-in-man clinical research.

News

Breakthrough in fight against neglected tropical disease

Posted on Friday 9 June 2017

Scientists say they have made a major breakthrough in the search for an effective vaccine for the neglected tropical disease leishmaniasis following the successful completion of a first in-human trial.


Biology PA nominated for 2 awards at this years Yorkshire PA of the Year Awards

Posted on Thursday 1 June 2017

Jenny Purcell is nominated in 2 categories which are for her work in the Biology Department


PhD Studentship in Computational Biology / Immunology at the University of York

Posted on Thursday 11 May 2017

Applications are invited for a 3-year PhD studentship funded by the Hull York Medical School at the University of York


Research

The Centre for Immunology and Infection is structured into three overlapping research areas: clinical and translational researchimmunology, and pathogen biology.

The Centre's researchers are involved in two major interdisciplinary collaborations:

Events

Mon
17
Jul

Ad-hoc ... Title TBC

1.00PM, K018

Dr Charles Mowbray, Drugs for Neglected Diseases Initiative (DNDi), Geneva

Study at CII